Natera stock is trading -9.31% below its average target price of $176.87 after dropping -4.8% during today's afternoon session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $37.0 to $210.0 per share.
Natera's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.4%. The stock's short ratio is 3.97. The company's insiders own 3.45% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 93.4%. In conclusion, we believe there is positive market sentiment regarding Natera.
Institutions Invested in Natera
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 11,437,007 | $1,834,495,852 |
| 2024-09-30 | Blackrock Inc. | 6% | 8,233,006 | $1,320,574,112 |
| 2024-09-30 | JP Morgan Chase & Company | 4% | 4,632,029 | $742,977,423 |
| 2024-09-30 | Farallon Capital Management LLC | 3% | 4,557,309 | $730,992,335 |
| 2024-09-30 | Fred Alger Management, LLC | 3% | 4,012,000 | $643,524,775 |
| 2024-09-30 | Duquesne Family Office Llc | 3% | 3,566,850 | $572,122,718 |
| 2024-09-30 | State Street Corporation | 3% | 3,494,340 | $560,492,114 |
| 2024-09-30 | Price (T.Rowe) Associates Inc | 2% | 2,870,566 | $460,438,768 |
| 2024-09-30 | Wellington Management Group, LLP | 2% | 2,800,263 | $449,162,168 |
| 2024-09-30 | RTW Investments LP | 2% | 2,593,323 | $415,968,993 |
